Clinical trial · Interventional
Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets and products for pancreaticobiliary cancer patients. The investigators expect that nutritional supplement for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreaticobiliary Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Routine care | Other | — | UNRESOLVED |
| Routine care + Nutritional product | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- experimental group
- interventionNames
- Dietary Supplement: Routine care + Nutritional product
- type
- ACTIVE_COMPARATOR
- label
- control group
- interventionNames
- Other: Routine care
Primary outcomes (3)
- measure
- Food Intake Rate(%) for postoperative diet
- timeFrame
- Pre-operation
- description
- Diet Intake Rate(%)
- measure
- Food Intake Rate(%) for postoperative diet
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Adult (age more than 19) * Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal pancreatectomy * Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater cancer Exclusion Criteria: * Patient who denied clinical trial * Diabetes Mellitus(DM) patient with DM complication * Hyperlipidemia patient with vascular co-morbidity * Impaired renal function or renal failure (GFP\<70%) * Poor nutritional status (PG-SGA grade C)
References
Publications (0)
Data not yet available